Gary L. Eddy

Treatment of (“bulky”) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: A phase III trial of the gynecologic oncology group

Gary L. Eddy, Brian N. Bundy, William T. Creasman et al. · Gynecologic Oncology · 2007 · 160 citations

Cervical Cancer Management, Surgical Oncology, Cervical Cancer +11

Fallopian Tube Carcinoma

Gary L. Eddy, L. Copeland, David M. Gershenson et al. · Gynecologic Oncology · 2009 · 110 citations

Surgical Oncology, Tumoral Pathology, Gynecological Surgery +14

Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda system

Gary L. Eddy, Kenneth B. Strumpf, Martha Wojtowycz et al. · American Journal of Obstetrics and Gynecology · 1997 · 82 citations

Tumoral Pathology, Uncertain Significance, Surgical Pathology +8

Neoadjuvant Chemotherapy with Vincristine and Cisplatin Followed by Radical Hysterectomy and Pelvic Lymphadenectomy for FIGO Stage IB Bulky Cervical Cancer: A Gynecologic Oncology Group Pilot Study

Gary L. Eddy, Alberto Manetta, Ronald D. Alvarez et al. · Gynecologic Oncology · 1995 · 67 citations

Surgical Oncology, Gynecological Surgery, Cervical Cancer +9

Primary invasive vaginal carcinoma

Gary L. Eddy, Richard D. Marks, M. Clinton Miller et al. · American Journal of Obstetrics and Gynecology · 1991 · 63 citations

Tumoral Pathology, Vulvar Diseases, Medicine +4